1. bookVolume 29 (2021): Issue 3 (July 2021)
Journal Details
License
Format
Journal
First Published
08 Aug 2013
Publication timeframe
4 times per year
Languages
English
access type Open Access

Genetic Diagnostic Approaches in Familial Hypercholesterolemia Evaluation

Published Online: 31 Jul 2021
Page range: 319 - 325
Received: 30 Jun 2021
Accepted: 14 Jul 2021
Journal Details
License
Format
Journal
First Published
08 Aug 2013
Publication timeframe
4 times per year
Languages
English
Abstract

Familial hypercholesterolemia (FH) manifested as atherosclerosis is a major cause of coronary heart disease. Different scoring systems based on clinical and paraclinical data are currently used, but the FH diagnosis should be made only in the presence of the causative genetic defect. In the present study, 12 symptomatic (previously diagnosed with atherosclerosis) and asymptomatic family members were investigated. Serum lipids were measured using commercial reagents. A genetic investigation was performed by Sanger sequencing using commercial reagents and custom primers, while copy number variations and a selected set of 40 point mutations were evaluated using in vitro diagnostic medical devices. For the investigated patients, serum lipids were within the reference range, due to the fact that the subjects were following lipid-lowering therapy, and smoking was the only identifiable additional risk factor. Four benign exon variants and three intron variants situated within the low-density lipoprotein cholesterol receptor gene were identified by Sanger sequencing. No copy number variations and none of the 40 investigated point mutations were determined. Although independently considered benign, the combined effect of the identified genetic conditions could be pathogenic under the influence of additional risk factors. Even in the presence of a diagnosis made using clinical scores, the molecular diagnosis is often challenging, attesting to the complexity of FH genetic etiology.

Keywords

1. Nordestgaard BG, Chapman MJ, Humphries SE, Ginsberg HN, Masana L, Descamps OS, et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: Guidance for clinicians to prevent coronary heart disease. Eur Heart J 2013;34:3478-90. DOI: 10.1093/eurheartj/eht273 Search in Google Scholar

2. McGowan MP, Hosseini Dehkordi SH, Moriarty PM, Duell PB. Diagnosis and Treatment of Heterozygous Familial Hypercholesterolemia. J Am Heart Assoc 2019;8:e013225. DOI: 10.1161/JAHA.119.013225 Search in Google Scholar

3. Khera A V., Hegele RA. What Is Familial Hypercholesterolemia, and Why Does It Matter? Circulation 2020;141:1760-3. DOI: 10.1161/CIRCULATIONAHA.120.046961 Search in Google Scholar

4. Vrablik M, Tichý L, Freiberger T, Blaha V, Satny M, Hubacek JA. Genetics of Familial Hypercholesterolemia: New Insights. Front Genet 2020;11:1183. DOI: 10.3389/fgene.2020.574474 Search in Google Scholar

5. Knowles JW, Rader DJ, Khoury MJ. Cascade screening for familial hypercholesterolemia and the use of genetic testing. JAMA - J Am Med Assoc 2017;318:381-2. DOI: 10.1001/jama.2017.8543 Search in Google Scholar

6. FH Score n.d. https://www.fhscore.eu/#/fhQuestionnaire (accessed June 23, 2021). Search in Google Scholar

7. Kõressaar T, Lepamets M, Kaplinski L, Raime K, Andreson R, Remm M. Primer3-masker: Integrating masking of template sequence with primer design software. Bioinformatics 2018;34:1937-8. DOI: 10.1093/bioinformatics/bty036 Search in Google Scholar

8. SNPCheck n.d. https://genetools.org/SNPCheck/credits.htm (accessed June 20, 2021). Search in Google Scholar

9. UCSC In-Silico PCR n.d. https://genome.ucsc.edu/cgibin/hgPcr (accessed June 20, 2021). Search in Google Scholar

10. The LDLR gene homepage - Global Variome shared LOVD n.d. https://databases.lovd.nl/shared/genes/LDLR (accessed June 23, 2021). Search in Google Scholar

11. Bianconi V, Banach M, Pirro M. Why patients with familial hypercholesterolemia are at high cardiovascular risk? Beyond LDL-C levels. Trends Cardiovasc Med 2020;31:205-15. DOI: 10.1016/j.tcm.2020.03.004 Search in Google Scholar

12. Kramer A, Jansen ACM, Van Aalst-Cohen ES, Tanck MWT, Kastelein JJP, Zwinderman AH. Relative risk for cardiovascular atherosclerotic events after smoking cessation: 6-9 Years excess risk in individuals with familial hypercholesterolemia. BMC Public Health 2006;6:262. DOI: 10.1186/1471-2458-6-262 Search in Google Scholar

13. López G, Bernal LM, Gelvez N, Gómez LF, Nova A, Sánchez AI, et al. Mutational analysis of the LDLR gene in a cohort of Colombian families with familial hypercholesterolemia. Atherosclerosis 2018;277:434-9. DOI: 10.1016/j.atherosclerosis.2018.08.052 Search in Google Scholar

14. Paththinige CS, Rajapakse JRDK, Constantine GR, Sem KP, Singaraja RR, Jayasekara RW, et al. Spectrum of low-density lipoprotein receptor (LDLR) mutations in a cohort of Sri Lankan patients with familial hypercholesterolemia - A preliminary report. Lipids Health Dis 2018;17:1-7. DOI: 10.1186/s12944-018-0763-z Search in Google Scholar

15. rs1359242501 (SNP) - Population genetics - Homo_sapiens - Ensembl genome browser 104 n.d. https://www.ensembl.org/Homo_sapiens/Variation/Population?db=core;r=19:11133036-11134036;v=rs1359242501;vdb=variation;vf=390978283 (accessed June 24, 2021). Search in Google Scholar

16. Search: rs1359242501 - NLM n.d. https://www.ncbi.nlm.nih.gov/search/all/?term=rs1359242501 (accessed June 24, 2021). Search in Google Scholar

17. rs1359242501 - Google search. https://www.google.com/search?q=rs1359242501 (accessed June 24, 2021). Search in Google Scholar

18. VCV000183138.6 - ClinVar - NCBI n.d. https://www.ncbi.nlm.nih.gov/clinvar/variation/183138/#id_second (accessed June 24, 2021). Search in Google Scholar

19. De Oliveira F, Berretta J, De Almeida Junior G, De Almeida S, Chen E, Smith M, et al. Pharmacogenetic analyses of variations of measures of cardiovascular risk in Alzheimer’s dementia. Indian J Med Res 2019;150:261-71. DOI: 10.4103/ijmr.IJMR_1209_17 Search in Google Scholar

20. VCV000200916.5 - ClinVar - NCBI n.d. https://www.ncbi.nlm.nih.gov/clinvar/variation/200916/ (accessed June 24, 2021). Search in Google Scholar

21. Ekrami M, Torabi M, Ghafouri-Fard S, Mowla J, Soltani BM, Hashemi-Gorji F, et al. Genetic analysis of Iranian patients with familial hypercholesterolemia. Iran Biomed J 2018;22:117-22. Search in Google Scholar

22. Komarova TY, Korneva VA, Kuznetsova TY, Golovina AS, Vasilyev VB, Mandelshtam MY. Familial hypercholesterolemia mutations in Petrozavodsk: No similarity to St. Petersburg mutation spectrum. BMC Med Genet 2013;14:1-5. DOI: 10.1186/1471-2350-14-128 Search in Google Scholar

23. VCV000252262.5 - ClinVar - NCBI n.d. https://www.ncbi.nlm.nih.gov/clinvar/variation/252262/ (accessed June 24, 2021). Search in Google Scholar

24. Chiang HL, Wu JY, Chen YT. Identification of functional single nucleotide polymorphisms in the branch-point site. Hum Genomics 2017;11:1-6. DOI: 10.1186/s40246-017-0122-6 Search in Google Scholar

25. Safarova MS, Satterfield BA, Fan X, Austin EE, Ye Z, Bastarache L, et al. A phenome-wide association study to discover pleiotropic effects of PCSK9, APOB, and LDLR. Npj Genomic Med 2019;4. DOI: 10.1038/s41525-019-0078-7 Search in Google Scholar

26. Reeskamp LF, Tromp TR, Defesche JC, Grefhorst A, Stroes ES, Hovingh GK, et al Next-generation sequencing to confirm clinical familial hypercholesterolemia. Eur J Prev Cardiol. 2020 Jul 27:2047487320942996. DOI: 10.1177/2047487320942996 Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo